No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
BCAL Diagnostics Signs License Deal With Sydney Breast Clinic for Cancer Screening Technology
BCAL Diagnostics Limited's (ASX:BDX) Profit Outlook
BCAL Diagnostics Ltd: Appendix 4E and Annual Report to Shareholders
BCAL Diagnostics Forms US Subsidiary; Shares Down Nearly 4%
BCAL Diagnostics Shares Resume Trading After Equity Raising Announcement
BCAL Diagnostics Receives Firm Commitments for AU$10.5 Million Placement at AU$0.10 Per Share